CD9 Inhibitoren

Gängige CD9 Inhibitors sind unter underem Simvastatin CAS 79902-63-9, Ezetimibe CAS 163222-33-1, Genistein CAS 446-72-0, Resveratrol CAS 501-36-0 und Curcumin CAS 458-37-7.

CD9, a member of the tetraspanin superfamily, is a cell surface protein characterized by its four transmembrane domains. Tetraspanins, including CD9, are known for their capability to form complex networks on the cell surface, often referred to as 'tetraspanin-enriched microdomains' (TEMs). These microdomains are involved in the organization of various membrane proteins and play crucial roles in numerous cellular processes, such as cell adhesion, motility, and signal transduction. CD9, in particular, has been implicated in the modulation of cell migration, fusion, and differentiation. Furthermore, CD9 plays a significant role in the formation and function of extracellular vesicles, especially exosomes, which are vital for intercellular communication.

CD9 inhibitors are chemical entities designed to specifically target and modulate the function of CD9. By inhibiting CD9, these compounds can influence the formation and dynamics of TEMs, thereby altering the myriad cellular processes that these microdomains regulate. The mode of action of CD9 inhibitors can be diverse; some can prevent the proper localization of CD9 in the cell membrane, while others might obstruct its interaction with partner proteins essential for the formation of TEMs. Additionally, certain inhibitors could target the downstream signaling pathways activated by CD9.